Xue Zhang

Xue Zhang

Auto-generated profile, based on publicly available information

Xue Zhang

Department of Clinical Medicine, Chengdu Medical College, Chengdu, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2026 in Kidney Research and Clinical Practice
Verified
Journal Article
Closed access
XLXiunan Liu
Xiunan Liu
ZLZhuoxing Li
Zhuoxing Li
HLHao Liu
Hao Liu
MXMao Xiao
Mao Xiao
XZXue Zhang
Xue Zhang
XXXiang Xiao
Xiang Xiao
Medical nutrition therapy serves as the cornerstone in the management of chronic kidney disease (CKD). While conventional approaches emphasize macronutrient restriction and meal timing adjustments, research highlights the critical mediating role of gut microbiota in translating dietary patterns into physiological effects through metabolite production. Meanwhile, CKD progression is closely associated with dynamic interactions between gut microbiota and their metabolic derivatives. This review introduces the "diet-microbiota- metabolite-kidney axis" framework to elucidate how nutritional components modulate CKD progression via microbial compositional changes and subsequent metabolite alterations. Based on synthesized evidence, this review identifies promising directions for precision nutrition strategies targeting microbial metabolites, including artificial intelligence-assisted dietary planning, engineered bacterial therapies, and metabolite analog development. However, significant interindividual variability in host genetics and baseline microbiota composition necessitates overcoming heterogeneity challenges in nutritional interventions. Consequently, the precise modulation of individualized diet-microbiota-metabolite interactions represents a critical research direction to be prioritized in CKD management.